- Home
- ZTO vs ITCI Comparison
ZTO vs ITCI Comparison
Compare ZTO & ITCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZTO
- ITCI
- Stock Information
- Founded
- ZTO 2002
- ITCI 2002
- Country
- ZTO China
- ITCI United States
- Employees
- ZTO N/A
- ITCI N/A
- Industry
- ZTO Advertising
- ITCI Biotechnology: Pharmaceutical Preparations
- Sector
- ZTO Consumer Discretionary
- ITCI Health Care
- Exchange
- ZTO Nasdaq
- ITCI Nasdaq
- Market Cap
- ZTO 15.1B
- ITCI 13.5B
- IPO Year
- ZTO 2016
- ITCI N/A
- Fundamental
- Price
- ZTO $19.10
- ITCI $126.20
- Analyst Decision
- ZTO Strong Buy
- ITCI Buy
- Analyst Count
- ZTO 4
- ITCI 13
- Target Price
- ZTO $28.88
- ITCI $100.31
- AVG Volume (30 Days)
- ZTO 2.1M
- ITCI 4.3M
- Earning Date
- ZTO 11-19-2024
- ITCI 02-20-2025
- Dividend Yield
- ZTO 5.08%
- ITCI N/A
- EPS Growth
- ZTO N/A
- ITCI N/A
- EPS
- ZTO 1.49
- ITCI N/A
- Revenue
- ZTO $5,984,810,313.00
- ITCI $613,728,000.00
- Revenue This Year
- ZTO $14.66
- ITCI $48.41
- Revenue Next Year
- ZTO $10.52
- ITCI $38.26
- P/E Ratio
- ZTO $12.80
- ITCI N/A
- Revenue Growth
- ZTO 11.44
- ITCI 46.08
- 52 Week Low
- ZTO $15.90
- ITCI $62.78
- 52 Week High
- ZTO $27.50
- ITCI $128.00
- Technical
- Relative Strength Index (RSI)
- ZTO 48.73
- ITCI 85.88
- Support Level
- ZTO $18.25
- ITCI $126.00
- Resistance Level
- ZTO $18.78
- ITCI $128.00
- Average True Range (ATR)
- ZTO 0.38
- ITCI 2.35
- MACD
- ZTO 0.03
- ITCI 4.86
- Stochastic Oscillator
- ZTO 64.36
- ITCI 96.18
About ZTO ZTO Express (Cayman) Inc. each representing one ordinary share.
ZTO Express is China's largest express delivery company by parcel volume, with a volume share of 22.1% in 2022. It operates a network partner model where it provides line-haul transportation and sorting services, while its local network partners provide first-mile pickup and last-mile delivery services under the ZTO brand name. Headquartered in Shanghai, the company was founded in 2002 by Meisong Lai, who remains chair, CEO, and its major shareholder with 77% voting rights as of June 30, 2023. ZTO's strategic shareholder is leading China e-commerce company Alibaba Group with around an 11.7% interest.
About ITCI Intra-Cellular Therapies Inc.
Intra-Cellular Therapies Inc is a biopharmaceutical company that develops novel drugs for treating diseases of the central nervous system. The company is focused on the delivery and clinical development of small-molecule drugs that address needs in neuropsychiatric and neurological disorders. Intra-Cellular maintains proprietary chemistry platforms to develop drugs for neurodegenerative diseases. The company's business segment is discovering and developing drugs for the treatment of neurological and psychiatric disorders.